Part of the challenge for developing innovative new medicines is getting enough patients to enroll in clinical trials. But it’s not enough to enroll patients in these studies. Patients need to keep returning to clinical trial sites in order for those drug studies to be conducted in a complete and timely fashion. One solution might […]
